Can a Plant-Based compound stop deadly clots in pancreatic cancer?

NCT ID NCT06861088

Recruiting now Disease control Sponsor: Quercis Pharma AG Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 3 trial tests whether Kinisoquin™, a supplement-like drug made from isoquercetin plus vitamins C and B3, can prevent dangerous blood clots in 480 people with advanced pancreatic cancer. Participants receive either Kinisoquin™ or a placebo alongside their first chemotherapy. The study tracks clot events over 16 weeks to see if the drug reduces risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Kinisoquin™ (isoquercetin with vitamin C and vitamin B3)
What this could lead to: If it works, this could provide a new way to prevent life-threatening blood clots in people with advanced pancreatic cancer, potentially improving survival and quality of life.
What could go wrong: This is a large Phase 3 trial, but the drug may not reduce clot risk more than placebo. Side effects or interactions with chemotherapy are possible. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic adenocarcinoma pancreatic neoplasm pulmonary embolism Thromboembolism venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA METASTATIC PANCREATIC CANCER VENOUS THROMBOEMBOLISM

Contacts and locations

Locations

Beth Israel Deaconess Medical Center
RECRUITING

Boston, Massachusetts, 02215, United States
Clavis Medical, LLC
RECRUITING

Miami Lakes, Florida, 33014, United States
Ventura Clinical Trials
RECRUITING

Ventura, California, 93003, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.